Brunner, H. Et Al. 2023. Efficacy and Safety of Secukinumab in Juvenile Idiopathic Arthritis: Interim Results from the Extension of the JUNIPERA Trial. ARTHRITIS & RHEUMATOLOGY , 729-731.

Brunner, H., Foeldvari, I., Alexeeva, E., AKTAY AYAZ, N., Schulert, G., ÖZEN, S., ... Popov, A.(2023). Efficacy and Safety of Secukinumab in Juvenile Idiopathic Arthritis: Interim Results from the Extension of the JUNIPERA Trial. ARTHRITIS & RHEUMATOLOGY , 729-731.

Brunner, Hermine Et Al. "Efficacy and Safety of Secukinumab in Juvenile Idiopathic Arthritis: Interim Results from the Extension of the JUNIPERA Trial," ARTHRITIS & RHEUMATOLOGY , 729-731, 2023

Brunner, Hermine Et Al. "Efficacy and Safety of Secukinumab in Juvenile Idiopathic Arthritis: Interim Results from the Extension of the JUNIPERA Trial." ARTHRITIS & RHEUMATOLOGY , pp.729-731, 2023

Brunner, H. Et Al. (2023) . "Efficacy and Safety of Secukinumab in Juvenile Idiopathic Arthritis: Interim Results from the Extension of the JUNIPERA Trial." ARTHRITIS & RHEUMATOLOGY , pp.729-731.

@article{article, author={Hermine Brunner Et Al. }, title={Efficacy and Safety of Secukinumab in Juvenile Idiopathic Arthritis: Interim Results from the Extension of the JUNIPERA Trial}, journal={ARTHRITIS & RHEUMATOLOGY}, year=2023, pages={729-731} }